October 25, 2018 Clinical Research/Diagn. M&A, Partnerships

GE Healthcare and Shirazi Trading host continuous educational workshops for Pakistan’s leading cardiologists and radiologists

Islamabad, Pakistan; October 08, 2018: GE Healthcare (NYSE: GE), in collaboration with Shirazi Trading, held a series of Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Imaging workshops in Rawalpindi, Pakistan. The workshops, led by renowned cardiologist Dr. Saima Mushtaq, GE Healthcare’s Clinical Leaders for CT and MRI, Murat Karakoc and Dr. Ibrahim Elmogy, brought... Read more

October 24, 2018 Clinical Research/Diagn.

Recently released: 2 new Ph. Eur. Reference standards Zoledronic acid monohydrate and Infliximab BRP, as well as 16 replacement batches Back

PRODUCTS AND SERVICES NEWS 24 OCTOBER 2018 STRASBOURG, FRANCE 2 new Ph. Eur. Reference Standards and 16 replacement batches Y0002020 Zoledronic acid monohydrate  and Y0002110 Infliximab BRP Y0000740 Adrenaline impurity mixture, T1410000 Tiabendazole , E2250000 Ethosuximide impurity A, R0800000Rifampicin quinone , Y0000026 Sumatriptan impurity mixture, M0500000 Mepyramine maleate, C1950000Chlortalidone, T1899990 Triamcinolone, B1158000 Bumetanide , Y0000272 Oxaliplatin impurity B, Y0000073 Cetyl palmitate, Y0001341 Oseltamivir impurity H, H0200000 Heparin sodium BRP, B0305000 Beclometasone dipropionate anhydrous, S0150000  Salbutamol sulfate and A0575000 Amiodarone hydrochloride Content of the European Pharmacopoeia catalogue... Read more

October 24, 2018 Clinical Research/Diagn. Licensing, IP, and Legal

Agena and DaRui Biotechnology Announce China FDA Clearance of MassARRAY® Technology for Diagnostic Use in China

23 October 2018 San Diego, CA and Guangzhou, China, Wednesdy, October 24, 2018 – Agena Bioscience (Agena) and DaRui Biotechnolog (DaRui) announced today that the MassARRAY® System has formally passed the registration application of Guangdon Food and Drug Administration, becoming the first CFDA approved MALDI-TOF mass spectrometry system to directly detect nucleic acids for in vitro diagnostics in... Read more

October 23, 2018 Clinical Research/Diagn.

BD To Invest $200 Million In Nebraska Operations Creating 300 More Jobs

Brings Total Company Investment in Nebraska to $340 Million in Two Years COLUMBUS, Neb., Oct. 23, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to announce a $200 million investment in its facilities in Nebraska that will create 300 new jobs statewide. Today’s... Read more

October 22, 2018 Clinical Research/Diagn. M&A, Partnerships

Quanterix Announces Collaboration With Oncogenesis to Develop Cervical Screening Test

OCTOBER 22, 2018 Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection Lexington, Mass. – October 22, 2018 — Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration agreement with OncoGenesis, a molecular protein-based cervical screening company, to develop a quantitative, protein... Read more

October 22, 2018 Clinical Research/Diagn. M&A, Partnerships

Announcement of Participation in AMED Project “Research and development of core technologies for gene and cell therapy”

2018/10/22 Kusatsu/Shiga, Japan — October 22, 2018 – Takara Bio Inc. announces that it is participating in “Research and development of core technologies for gene and cell therapy” (Project) undertaken by Japan Agency for Medical Research and Development (AMED: https://www.amed.go.jp/en/index.html) since FY2018, under which Takara Bio will work on the development for large-scale production technologies of... Read more

October 18, 2018 Clinical Research/Diagn. M&A, Partnerships

Exact Sciences Strengthens Pipeline Capabilities With Acquisition Of Biomatrica, A Leading Provider Of Biological Sample Preservation Technology

10/18/2018 Technology Promotes High-Quality Results from Liquid Biopsy Cancer Tests MADISON, Wis. and SAN DIEGO, Oct. 18, 2018 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) today announced the acquisition of Biomatrica, a leading developer, manufacturer and provider of sample preservation technology, including blood and saliva sample collection tubes, to the biotech industry. Biomatrica’s sample collection... Read more

October 17, 2018 Clinical Research/Diagn. Lab Top-10 Product Launch

Thermo Fisher Scientific CE Marks Oncomine Dx Target Test

CARLSBAD, Calif., Oct. 17, 2018 /PRNewswire/ — Marking a milestone in bringing its Oncomine Dx Target Test to Europe, Thermo Fisher Scientific today announced that it has CE-IVD marked its next-generation sequencing (NGS)-based solution that screens biomarkers across solid tumors. Thermo Fisher will highlight the test during the European Society for Medical Oncology (ESMO) Congress... Read more

October 16, 2018 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools Product Launch

BD Launches Molecular Test For Detecting Tuberculosis And Multi-Drug Resistant TB

BD MAX™ MDR-TB Panel Obtains CE-IVD Status in Europe FRANKLIN LAKES, N.J., Oct. 16, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX™ MDR-TB panel in Europe. Clinicians can use the test to simultaneously detect bacteria that cause tuberculosis (TB) and determine if the bacteria... Read more

October 16, 2018 Clinical Research/Diagn.

Reminder: Invitation to Roche's live audio webcast at the 2018 European Society for Medical Oncology (ESMO) Congress

Basel, 16 October 2018 Reminder: Invitation to Roche’s live audio webcast at the 2018 European Society for Medical Oncology (ESMO) Congress We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Monday, 22 October 2018, to discuss key data presented on the Roche Group’s oncology portfolio and pipeline during the... Read more